Currently, EpCAM+CTCs have been intensively investigated in HCC, although the knowledge about their clinical relevance in HCC is lagging behind other major tumor types, such as breast cancer, prostate cancer and lung cancer [97]. This evidence concerns the gene EPCAM and hepatocellular carcinoma.